Navigation Links
Cognitive, genetic clues identified in imaging study of alcohol addiction
Date:12/25/2007

People with clinical addictions know first-hand the ravages the disease can take on almost every aspect of their lives. So why do they continue addictive behaviors, even after a period of peaceable abstinence"

Some answers appear rooted in regions of the brain active during decision making.

"It's perhaps not just that people are slaves to pleasure, but that they have trouble thinking through a decision," said Charlotte Boettiger, an assistant professor of psychology at the University of North Carolina at Chapel Hill, and lead author of a study in the December issue of the Journal of Neuroscience that took a novel tack in addiction imaging research.

"Our data suggest there may be a cognitive difference in people with addictions," Boettiger said. "Their brains may not fully process the long-term consequences of their choices. They may compute information less efficiently."

The study also found that a variant of the COMT gene, which controls the level of the neurotransmitter dopamine in the cortex, was associated with a tendency to make impulsive decisions and with high activity in certain brain areas during decision making.

Current medications for addictions are not universally effective; many either mimic the addictive substance to help people get through withdrawal periods or block the substance to prevent its effects. For stimulants, such as methamphetamines, there are no therapies yet, Boettiger said.

"What's exciting about this study is that it suggests a new approach to therapy. We might prescribe medications, such as those used to treat Parkinson's or early Alzheimer's disease, or tailor cognitive therapy to improve executive function," said Boettiger, who led the study as scientist at the University of California, San Francisco's Gallo Clinic and Research Center.

"I am very excited about these results because of their clinical implications," said Dr. Howard Fields, a professor of neurolog
'/>"/>

Contact: Clinton Colmenares
919-218-7833
University of North Carolina at Chapel Hill
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... just as vital to your health as what you eat, fou...l Studies. Their experiments in mice revealed that... in the liverthe body,s metabolic clearinghouseis ...dy,s circadian clock as conventional wisdom had it... a large number of genes completely independent of...
(Date:11/24/2009)...bby arteries from collapsing have been true life-s...onger needed -- once the arteries are strengthened... no choice but to leave them in place. , Prof. M...t of Biomedical Engineering has developed a new pa...re they,re needed, then dissolves. , "Our new co...
(Date:11/24/2009)...matter of debate. A high-profile study a few years...their carbon from trees and leaves, evidence for a...ic ecosystems. , But new research from the Unive... true. Algae provide a much richer diet for fish a...shed this week in the Proceedings of the National...
Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 1Greg Fischer Named AvMed Health Plans New Senior Vice President of Sales and Marketing 53911 2Omega Protein Reports 2009 Second Quarter Results 53906 1Omega Protein Reports 2009 Second Quarter Results 53906 2Omega Protein Reports 2009 Second Quarter Results 53906 3Omega Protein Reports 2009 Second Quarter Results 53906 4Omega Protein Reports 2009 Second Quarter Results 53906 5Omega Protein Reports 2009 Second Quarter Results 53906 6GenVec Reports Second Quarter 2009 Financial Results 13434 1GenVec Reports Second Quarter 2009 Financial Results 13434 2GenVec Reports Second Quarter 2009 Financial Results 13434 3GenVec Reports Second Quarter 2009 Financial Results 13434 4GenVec Reports Second Quarter 2009 Financial Results 13434 5GenVec Reports Second Quarter 2009 Financial Results 13434 6GenVec Reports Second Quarter 2009 Financial Results 13434 7
...nthetically engineered tissues such as muscle or c...orward, Cornell engineers describe in the journal ...e developed that can nourish growing tissues., The...a water-based gel that mimic a vascular system at ...l nutrients and growth factors to feed individual ...
...chi, Ph.D., distinguished professor of human genet...Institute of Human Genetics and a Howard Hughes Me...el Prize in Physiology or Medicine. , The announc...at the Karolinska Institute, in Stockholm, Sweden....ment of knockout mice technology, a gene-targeting...
...earchers at Columbia University Mailman School of ...n dramatically lower blood arsenic levels in indiv...nking water. This toxic element, naturally presen... a significant public health problem in at least 7...s and also parts of the U.S. Chronic arsenic expo...
Other Biology News:Researchers create system to build transplant tissue 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 2Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine 3Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 2Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study 3
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009)...patientswithadvanced-stage,orrecurrentendometrialc...ll/-AEternaZentarisInc.(NASDAQ: AEZS ;TSX:AEZ)(the...nendocrinetherapyandoncology,todayannouncedpositiv...xicpeptideconjugate,AEZS-108(formerlyAN-152),inpat...ersonalizedhealthcareapproach,thestudyselectedpati...
(Date:11/24/2009)...ll/--Shireplc(LSE:SHP,NASDAQ: SHPGY ),theglobalsp...tithassubmittedaMAAtotheEuropeanMedicinesAgencyfor...erapyindevelopment,forthetreatmentofType1Gaucherdi...ucerasealfathathasbeensubmitted,withprevious,submi...lobalsupplyshortageofthecurrentlyapprovedandmarket...
(Date:11/24/2009)...-FirstCall/--GenomicHealth,Inc.(Nasdaq: GHDX )toda...hairman,willpresentatthe21stAnnualPiperJaffrayHeal...009at10:00a.m.ET. ,, Toaccesstheliveandsubseque...torRelationssectionofGenomicHealth,swebsiteat http...ebsiteatleast15minutespriortothebeginningofthepres...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Genomic Health to Present at Piper Jaffray Health Care Conference 2
...S, Calif., May 6 Amgen (Nasdaq: AMGN ), today a... Meeting of Stockholders, held at The St. Regis Ho...cent of outstanding shares were represented at the...ore, Frank J. Biondi, Jr., Francois de Carbonnel, ...uck, Frank C. Herringer, Gilbert S. Omenn, Judith ...
...ay 6 ChanTest, the leading expert in ion channels... drug discovery, development, and safety -- is one...through Ohio,s Third Frontier Research and Commerc...terim Director of the Ohio Department of Developme..., Mark Barbash, announced the competitive grants l...
...y 6 /PRNewswire/ - Technology experts from over 20...ns on energy and the environment, topics of global...icromachine Summit is an international forum to di...ologies and the way in which they deliver economic...ue amongst the delegates of scientists, researcher...
Other Biology Technology:Amgen Announces Voting Results Of Annual Meeting Of Stockholders 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 2ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program 3World Micromachine Summit highlights technologies impacting energy and the environment 2
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Silencer siRNA Starter Kit from Ambion
Goat Anti-VAV2 Antibody, Unconjugated from Raybiotech, Inc.
Anti-Indoleamine 2,3-dioxygenase (IDO) Monoclonal Antibody, Unconjugated from CHEMICON
Biology Products: